Cargando…

Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge

PURPOSE: The aim of this study was to evaluate outcomes of hypofractionated stereotactic radiation therapy (HSRT) in patients re-treated for recurrent high-grade glioma. MATERIALS AND METHODS: From January 2006 to September 2013, 25 patients were treated. Six patients underwent radiation therapy alo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarria, Pierina, Ascolese, Anna Maria, Tomatis, Stefano, Reggiori, Giacomo, Clerici, Elena, Villa, Elisa, Maggi, Giulia, Bello, Lorenzo, Pessina, Federico, Cozzi, Luca, Scorsetti, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720100/ https://www.ncbi.nlm.nih.gov/pubmed/25761491 http://dx.doi.org/10.4143/crt.2014.259

Ejemplares similares

Outcome Evaluation of Oligometastatic Patients Treated with Surgical Resection Followed by Hypofractionated Stereotactic Radiosurgery (HSRS) on the Tumor Bed, for Single, Large Brain Metastases
por: Pessina, Federico, et al.
Publicado: (2016)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
por: Navarria, Pierina, et al.
Publicado: (2014)

Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma
por: Scorsetti, Marta, et al.
Publicado: (2015)

Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection
por: Navarria, Pierina, et al.
Publicado: (2016)

Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study
por: Navarria, Pierina, et al.
Publicado: (2017)

Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy
por: Navarria, Pierina, et al.
Publicado: (2016)

Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: report of dosimetric and early clinical results in oligometastatic patients
por: Alongi, Filippo, et al.
Publicado: (2012)

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach
por: Comito, Tiziana, et al.
Publicado: (2014)

11C Choline PET Guided Salvage Radiotherapy with Volumetric Modulation Arc Therapy and Hypofractionation for Recurrent Prostate Cancer after HIFU Failure: Preliminary Results of Tolerability and Acute Toxicity
por: Alongi, Filippo, et al.
Publicado: (2014)

Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study
por: Alongi, Filippo, et al.
Publicado: (2013)

Radiosurgery of limited brain metastases from primary solid tumor: results of the randomized phase III trial (NCT02355613) comparing treatments executed with a specialized or a C-arm linac-based platform
por: Scorsetti, Marta, et al.
Publicado: (2023)

SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience
por: Tozzi, Angelo, et al.
Publicado: (2013)

Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments
por: Scorsetti, Marta, et al.
Publicado: (2011)

Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up
por: Scorsetti, Marta, et al.
Publicado: (2018)

Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery
por: Franzese, Ciro, et al.
Publicado: (2017)

Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
por: Arpa, Donatella, et al.
Publicado: (2021)

Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results
por: De Rose, Fiorenza, et al.
Publicado: (2016)

Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma
por: Cozzi, Luca, et al.
Publicado: (2018)

Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients
por: Franceschini, Davide, et al.
Publicado: (2022)

The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation
por: Cozzi, Luca, et al.
Publicado: (2020)

Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy
por: Tozzi, Angelo, et al.
Publicado: (2014)

In-vivo dosimetry with Gafchromic films for multi-isocentric VMAT irradiation of total marrow lymph-nodes: a feasibility study
por: Mancosu, Pietro, et al.
Publicado: (2015)

Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study)
por: Comito, Tiziana, et al.
Publicado: (2023)

Evaluation of plan complexity and dosimetric plan quality of total marrow and lymphoid irradiation using volumetric modulated arc therapy
por: Lambri, Nicola, et al.
Publicado: (2023)

Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives
por: Persico, Pasquale, et al.
Publicado: (2021)

Automatic planning of the lower extremities for total marrow irradiation using volumetric modulated arc therapy
por: Lambri, Nicola, et al.
Publicado: (2022)

Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy
por: Franzese, Ciro, et al.
Publicado: (2015)

Multimodal Treatments for Brain Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective Study
por: Navarria, Pierina, et al.
Publicado: (2023)

Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma
por: Cozzi, Luca, et al.
Publicado: (2019)

Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience
por: Reynaud, Thomas, et al.
Publicado: (2018)

Collimator scatter factor: Monte Carlo and in-air measurements approaches
por: Fogliata, A., et al.
Publicado: (2018)

The impact of scanning data measurements on the Acuros dose calculation algorithm configuration
por: Fogliata, A., et al.
Publicado: (2020)

Stereotactic Radiotherapy for Ultra-Central Lung Oligometastases in Non-Small-Cell Lung Cancer
por: Loi, Mauro, et al.
Publicado: (2020)

Stereotactic body radiation therapy for liver tumours using flattening filter free beam: dosimetric and technical considerations
por: Mancosu, Pietro, et al.
Publicado: (2012)

Evaluation of target dose inhomogeneity in breast cancer treatment due to tissue elemental differences
por: Fogliata, A., et al.
Publicado: (2018)

Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience
por: Guan, Yun, et al.
Publicado: (2021)

Dosimetric impact of inter-observer variability for 3D conformal radiotherapy and volumetric modulated arc therapy: the rectal tumor target definition case
por: Lobefalo, Francesca, et al.
Publicado: (2013)

Adaptive Volumetric-Modulated Arc Radiation Therapy for Head and Neck Cancer: Evaluation of Benefit on Target Coverage and Sparing of Organs at Risk
por: Franzese, Ciro, et al.
Publicado: (2023)

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma
por: Vordermark, Dirk, et al.
Publicado: (2005)

Preoperative [(11)C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas
por: Ninatti, Gaia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e3lkd7rrd1k8pno28d3fftn8on